Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: A prospective study using novel cardiac imaging and biochemical markers

International Journal of Cardiology

Volumn 168, Issue 6, 2013, Pages 5465-5467

  Grover, Suchi ^a   Leong, Darryl P ^a   Chakrabarty, Adhiraj ^a   Joerg, Lucas ^a   Kotasek, Dusan ^b,c   Cheong, Kerry ^b,c   Joshi, Rohit ^d   Joseph, Majo X ^a   Depasquale, Carmine ^a   Koczwara, Bogda ^a   Selvanayagam, Joseph B ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b Adelaide Cancer Centre   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d LYELL MCEWIN HOSPITAL   (Australia)

Author keywords

Anthracyclines; Cardiotoxicity; Chemotherapy; Myocardial oedema; Right ventricle; Trastuzumab

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; EPIRUBICIN; TAXANE DERIVATIVE; TRASTUZUMAB; TROPONIN T;

ADULT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; ELECTROCARDIOGRAM; ENZYME INHIBITION; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICULOGRAPHY; HUMAN; LATISSIMUS DORSI MUSCLE; LETTER; MULTIPLE CYCLE TREATMENT; MYOCARDIAL EDEMA; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE;

ANTHRACYCLINES; CARDIOTOXICITY; CHEMOTHERAPY; MYOCARDIAL OEDEMA; RIGHT VENTRICLE; TRASTUZUMAB;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARDIAC IMAGING TECHNIQUES; DOXORUBICIN; EPIRUBICIN; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84887187199     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.246     Document Type: Article

References (10)

1. M.G. Friedrich, H. Abdel-Aty, A. Taylor, J. Schulz-Menger, D. Messroghli, and R. Dietz The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance J Am Coll Cardiol 51 16 2008 1581 1587
2. R.J. Kim, E. Wu, and A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 20 2000 1445 1453
3. M.G. Friedrich, U. Sechtem, and J. Schulz-Menger Cardiovascular magnetic resonance in myocarditis: a JACC White Paper J Am Coll Cardiol 53 17 2009 1475 1487
4. K. Alfakih, S. Reid, T. Jones, and M. Sivananthan Assessment of ventricular function and mass by cardiac magnetic resonance imaging Eur Radiol 14 10 2004 1813 1822
5. T. Nousiainen, E. Vanninen, and E. Jantunen Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy J Intern Med 249 4 2001 297 303
6. J. Alexander, N. Dainiak, and H.J. Berger Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography N Engl J Med 300 6 1979 278 283
7. I. Mitani, D. Jain, T.M. Joska, B. Burtness, and B.L. Zaret Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era J Nucl Cardiol 10 2 2003 132 139
8. E.C. Barendswaard, H. Prpic, E.E. Van der Wall, J.A. Camps, H.J. Keizer, and E.K. Pauwels Right ventricle wall motion abnormalities in patients treated with chemotherapy Clin Nucl Med 16 7 1991 513 516
9. S. Ghio, A. Gavazzi, and C. Campana Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure J Am Coll Cardiol 37 1 2001 183 188
10. A. Tanindi, U. Demirci, and G. Tacoy Assessment of right ventricular functions during cancer chemotherapy Eur J Echocardiogr 12 11 2011 834 840